Form D · Other

Cadence Biomedical, Inc.

Seattle, WA · CIK 0001533465

Offering snapshot reported Jun 9, 2016 · SEC filing

Reported sold: $103K
Investors reported: 10
Minimum accepted: $0
First sale: Mar 24, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$22,686 → $102,686
Reported investors6 → 10

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 9, 2016	Amendment	$102,686	$80,000vs Mar 29, 2016	10	SEC filing
Mar 29, 2016	Initial	$22,686	No comparison	6	SEC filing
Mar 24, 2015	Initial	$959,578	No comparison	26	SEC filing
Feb 28, 2013	Amendment	$1,313,158	$1,048,158vs Jan 3, 2012	48	SEC filing
Jan 3, 2012	Initial	$265,000	No comparison	19	SEC filing
Oct 25, 2011	Initial	$255,000	No comparison	6	SEC filing

Offering details

Securities: Debt
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-260224

Source: Form D, filed Jun 9, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
David Caro	Director
John Castle	Director
Brian Glaister	Executive
Barry Hix	Director, Executive
Michael Hovanes	Director, Executive, Promoter
Donna Jang	Director
Chie Kawahara	Executive
Rob Lewis	Director
Jason Pacanowsky	Executive
George Saul	Director
Jason Schoen	Executive

Issuer details

Industry: Other (See others in industry)

Address:

3534 Bagley Avenue N
Seattle, WA, 98103